Omega-3 Fatty Acids

Omega-3 fatty acids are essential polyunsaturated fats that the body cannot synthesize in sufficient quantity and must obtain from diet. The biologically active forms, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are found primarily in fatty fish, shellfish, and algae. ALA (alpha-linolenic acid), found in plant sources like flaxseed and walnuts, can convert to EPA and DHA but the conversion rate is low (typically under 10%). Omega-3s are among the most extensively studied nutritional compounds in the world.

Forms and Sources

Dietary sources of EPA and DHA include fatty fish (salmon, mackerel, sardines, anchovies, herring), shellfish, and algae-based products. Two to three servings of fatty fish per week provides approximately 1–2g EPA+DHA combined. Supplements (fish oil capsules, krill oil, and algae-based DHA) are widely used. Algae oil is a suitable plant-based source of preformed DHA, important for those who don’t consume fish. The EPA:DHA ratio varies by product and matters for specific applications (EPA is more relevant to mood and inflammation; DHA to brain structure).

Triglyceride Reduction {#triglyceride-reduction}

The most robustly established benefit of omega-3 supplementation is triglyceride reduction. At doses of 2–4g EPA+DHA per day, omega-3s reduce serum triglycerides by approximately 15–30% in people with elevated levels. This effect is consistent across dozens of RCTs and is strong enough that high-dose EPA (icosapentaenoic acid ethyl ester, Vascepa) is FDA-approved as a triglyceride-lowering medication. The mechanism involves reduced VLDL synthesis and accelerated triglyceride clearance.

Anti-inflammatory Effects {#anti-inflammatory}

EPA and DHA are incorporated into cell membrane phospholipids and serve as precursors to resolvins, protectins, and maresins: lipid mediators that actively resolve inflammation rather than simply suppressing it. They also compete with arachidonic acid (the precursor to pro-inflammatory eicosanoids), reducing the ratio of pro- to anti-inflammatory signaling. Meta-analyses of supplementation trials find consistent reductions in hs-CRP, IL-6, and TNF-α, with effect sizes larger in populations with elevated baseline inflammation (obesity, metabolic syndrome, autoimmune conditions).

Brain Health {#brain-health}

DHA constitutes approximately 10–20% of total brain fatty acid content and is concentrated in neuronal cell membranes and synaptic vesicles, where it modulates membrane fluidity and receptor function. Adequate DHA is critical during fetal brain development and remains important through life. In adults, DHA status is associated with cognitive performance in observational research, and supplementation studies show modest benefits for memory and processing speed, particularly in people with low baseline intake. The evidence for preventing cognitive decline is promising but not yet definitive.

Depression Support {#depression-support}

A meta-analysis of 26 RCTs found that omega-3 supplementation produces modest but significant improvements in depressive symptoms, with EPA showing stronger effects than DHA. Effects are most pronounced in formulations containing more than 60% EPA and in populations with clinical depression rather than healthy controls. The proposed mechanism involves EPA’s effects on inflammatory signaling pathways implicated in depressive disorder. Omega-3s are not a replacement for first-line depression treatment but represent a well-tolerated adjunct.

Cardiovascular Evidence

The cardiovascular story for omega-3 supplements is nuanced. Large cohort studies consistently show lower cardiovascular mortality in populations eating fatty fish regularly. However, supplementation trials tell a different story: a 2012 JAMA meta-analysis (Rizos et al., n=68,680 participants) found no statistically significant association between omega-3 supplementation and major cardiovascular events including heart attack and stroke. Subsequent high-dose trials (REDUCE-IT with icosapentaenoic acid) showed significant CV event reduction, but results have been debated due to the mineral oil placebo used. The current consensus: dietary omega-3 from fish is clearly beneficial for cardiovascular health; supplemental omega-3 benefit is more uncertain, with the strongest evidence at higher doses for people with elevated triglycerides.

Longevity and Biological Aging

Emerging evidence links omega-3 status directly to lifespan and the pace of biological aging. A 2021 analysis of the Framingham Offspring Cohort, tracking 2,240 adults over 11 years, found that the Omega-3 Index (red blood cell EPA+DHA content) was among the strongest predictors of all-cause mortality in the dataset. Adults with the highest Omega-3 Index had a 34% lower risk of dying from any cause and an estimated 4.7 years longer life expectancy than those with the lowest index , a gap similar in magnitude to the difference between smokers and non-smokers. This finding positions blood omega-3 status as a meaningful longevity biomarker alongside traditional risk factors.

A 2025 RCT from the DO-HEALTH trial (Nature Aging) tested the effects of 1g/day omega-3 supplementation in 777 older adults over three years. Supplementation slowed three of four validated epigenetic aging clocks (PhenoAge, GrimAge2, and DunedinPACE) by approximately three months relative to placebo. When omega-3 was combined with vitamin D (2,000 IU/day) and a home exercise program, additive effects were observed for PhenoAge, suggesting these interventions act through complementary pathways. The effect was largest in participants with lower baseline omega-3 intake, consistent with the hypothesis that correcting insufficiency drives the benefit.

Dosing

A general health dose is 1–2g combined EPA+DHA per day. For triglyceride reduction, 2–4g/day. For depression adjunct, formulations with high EPA content (at least 1g EPA/day) show more consistent effects. Fish oil should be stored properly to prevent oxidation (refrigerate after opening). Enteric-coated capsules reduce fishy aftertaste. Those on anticoagulants should consult a physician, as high-dose omega-3 may have mild blood-thinning effects.

Longevity Signal {#longevity-signal}

High omega-3 index linked to ~5 years longer life expectancy. The evidence and practical framing for this claim are covered in the page narrative above.